← Back to Search

Native Starch vs Modified Starch for Glycemic Responses

N/A
Waitlist Available
Led By Thomas MS Wolever, MD, PhD, DM (Oxon)
Research Sponsored by INQUIS Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 15, 30, 45, 60, 90, and 120 minutes after intervention administration
Awards & highlights

Study Summary

This trial will test how 2 different starches affect blood sugar levels after eating. Participants will eat 2 test foods & provide blood sugar samples for 2 hrs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~-5 to 120 minutes after intervention administration
This trial's timeline: 3 weeks for screening, Varies for treatment, and -5 to 120 minutes after intervention administration for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postprandial Glycemia
Secondary outcome measures
Incremental Blood Glucose

Trial Design

2Treatment groups
Experimental Treatment
Group I: Processed Starch, then Native StarchExperimental Treatment2 Interventions
Participants will first receive the Extrusion Processed Starch in a fasting state in one clinical visit. After a washout of >24 hours, the participants then will receive the Commercial Native Starch in a fasting state in one clinical visit.
Group II: Native Starch, then Processed StarchExperimental Treatment2 Interventions
Participants will first receive the Commercial Native Starch in a fasting state in one clinical visit. After a washout of >24 hours, the participants will then receive the Extrusion Processed Starch in a fasting state in one clinical visit.

Find a Location

Who is running the clinical trial?

INQUIS Clinical ResearchLead Sponsor
9 Previous Clinical Trials
305 Total Patients Enrolled
1 Trials studying Glycemic Responses
13 Patients Enrolled for Glycemic Responses
University of SaskatchewanOTHER
251 Previous Clinical Trials
154,390 Total Patients Enrolled
Thomas MS Wolever, MD, PhD, DM (Oxon)Principal InvestigatorINQUIS Clinical Research

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability for individuals to join this research project?

"According to clinicaltrials.gov, this particular trial is no longer recruiting patients. Initially posted on September 25th 2023 and last updated on the 15th of that same month, this investigation has concluded its search for subjects; however fortunately there are 2 other trials still in need of participants."

Answered by AI
~13 spots leftby Apr 2025